Menthone enhancement of transdermal drug delivery
US4873266A · kind A · utility
4Cited by
7References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 1987 |
| Grant date | Oct 10, 1989 |
| Priority date | — |
| Expiry date | Jan 16, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions and methods for enhancing the transdermal delivery of physiologically active agents across mammalian skin or membranes and which comprise a percutaneous transfer enhancing amount of 1-menthone and a drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.